Search Within

Steven M Horwitz

  1. "Dermatology"
Formats
  1. Meeting Abstract (39)
  2. Journal Article (35)
  3. Review (4)
  4. Research Letter (3)
  5. Correspondence (1)
Groups
  1. Center for Hematologic Malignancies (82)
  2. Department of Medicine (82)
  3. Dermatology (82)
  4. Division of Subspecialty Medicine (82)
  5. Hematologic Malignancies, Division of (82)
  6. Lymphoma (82)

More Groups

People
  1. Patricia Myskowski (74)
  2. Alison Moskowitz (54)
  3. Melissa Pulitzer (41)
  4. Christiane Querfeld (21)
  5. Shamir Geller (18)
  6. Sarah Noor (16)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (2)
  4. 2022 (3)
  5. 2021 (9)
  6. 2020 (5)

More Years

Publications
  1. Blood (25)
  2. Journal of the American Academy of Dermatology (12)
  3. Journal of Clinical Oncology (5)
  4. Annals of Oncology (3)
  5. Journal of Investigative Dermatology (3)
  6. Clinical Lymphoma, Myeloma and Leukemia (2)

More Publications

Publishers
  1. American Society of Hematology (25)
  2. Mosby Elsevier (12)
  3. Wiley Blackwell (9)
  4. American Society of Clinical Oncology (5)
  5. Elsevier Inc. (4)
  6. Elsevier Science, Inc. (3)

More Publishers

Results (82)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Management of cutaneous T cell lymphoma: New and emerging targets and treatment options
    Journal Article

    Li, J. Y.; Horwitz, S.; Moskowitz, A.; Myskowski, P. L.; Pulitzer, M.; Querfeld, C.
    Cancer Management and Research (2012)

    Fulltext@MSK | Save
  • RAS mutation analysis of transformed mycosis fungoides identifies a KRAS G13D mutation
    Meeting Abstract

    Connolly, B. M.; Hedvat, C.; Myskowski, P. L.; Horwitz, S. M.; Pulitzer, M. P.
    Modern Pathology (2012)

    Fulltext@MSK | Save
  • RAS mutation analysis of transformed mycosis fungoides identifies a KRAS G13D mutation
    Meeting Abstract

    Connolly, B. M.; Hedvat, C.; Myskowski, P. L.; Horwitz, S. M.; Pulitzer, M. P.
    Laboratory Investigation (2012)

    Fulltext@MSK | Save
  • Bexarotene is active against subcutaneous panniculitis-like T-cell lymphoma in adult and pediatric populations
    Journal Article

    Mehta, N.; Wayne, A. S.; Kim, Y. H.; Hale, G. A.; Alvarado, C. S.; Myskowski, P.; Jaffe, E. S.; Busam, K. J.; Pulitzer, M.; Zwerner, J.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2012)

    Fulltext@MSK | Save
  • Interim results of phase II trial of pegylated liposomal doxorubicin (PLD) followed by bexarotene in advanced cutaneous T-cell lymphoma (CTCL)
    Meeting Abstract

    Straus, D. J.; Duvic, M.; Horwitz, S. M.; Hymes, K. B.; Goy, A.; Hernandez-Ilizaliturri, F. J.; Feldman, T.; Wegner, B.; Myskowski, P.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Identification of an active, well-tolerated dose of pralatrexate in patients with relapsed or refractory cutaneous T-Cell lymphoma (CTCL): Final results of a multicenter dose-finding study
    Meeting Abstract

    Horwitz, S. M.; Kim, Y. H.; Foss, F. M.; Zain, J. M.; Myskowski, P.; Lechowicz, M. J.; Fisher, D. C.; Shustov, A.; Bartlett, N. L.; Delioukina, M. L.; more...
    Blood (2010)

    Fulltext@MSK | Save
  • Pralatrexate is active in cutaneous T-cell lymphoma (CTCL): Results of a multicenter, dose-finding trial
    Meeting Abstract

    Horwitz, S. M.; Duvic, M.; Kim, Y.; Zairi, J. M.; Lechowicz, M. J.; Myskowski, P.; Fruchtman, S.; O'Connor, O. A.
    Blood (2009)

    Fulltext@MSK | Save
  • Pralatrexate (PDX) is active in cutaneous T-cell lymphoma: Preliminary results of a multi-center dose-finding trial
    Meeting Abstract

    Horwitz, S. M.; Duvic, M.; Kim, Y.; Zain, J. M.; Lechowicz, M. J.; Myskowski, P.; Weissbrot, H.; Wright, D.; Chance, L.; Koutsoukos, T.; more...
    Blood (2008)

    Fulltext@MSK | Save
  • Low dose pralatrexate (PDX) is active in cutaneous T-cell lymphoma: Preliminary results of a multi-center dose finding trial
    Meeting Abstract

    Horwitz, S.; Duvic, M.; Kim, Y.; Chance, L.; Myskowski, P.; Talpur, R.; Morales, A.; Saunders, M.; O'connor, O.
    Annals of Oncology (2008)

    Fulltext@MSK | Save
  • Results of a phase II trial of oral bexarotene (Targretin) combined with interferon alfa-2b (Intron-A) for patients with cutaneous T-cell lymphoma
    Journal Article

    Straus, D. J.; Duvic, M.; Kuzel, T.; Horwitz, S.; Demierre, M. F.; Myskowski, P.; Steckel, S.
    Cancer (2007)

    Fulltext@MSK | Save